Read + Share
Amedeo Smart
Independent Medical Education
Lee YH, Kim DM, Yu JM, Choi KM, et al. Anagliptin twice-daily regimen improves glycemic variability in subjects with type 2 diabetes: Double-Blind, Randomized Controlled Trial. Diabetes Obes Metab 2022 Dec 23. doi: 10.1111/dom.14959.PMID: 36564983
Email
LinkedIn
Facebook
Twitter
Privacy Policy